In ancient times, people were willing to go to great lengths to prolong their lives. Now, a German company is hoping to make this possible.
The company, Tomorrow.Bio, is leading the way in human cryopreservation for $200,000. However, the question remains: Is this a true journey toward immortality or just an expensive fantasy?
In Berlin, Tomorrow.Bio has introduced a modified ambulance where the process of extending human life takes place. When a patient is legally declared dead, the body undergoes a highly complex preservation procedure in which blood is replaced with a cryoprotective agent that prevents ice crystals from forming within the tissues. This allows the body to cool down to negative 196°C. The body is then preserved at a facility in Switzerland.
Co-founder and cancer researcher Emil Kędziura says that cryonics could become as common as organ transplants. He pointed to the example of Anna Bäbgen Holm, who was trapped in ice for two hours, declared clinically dead, but was revived later as a demonstration of the constant progress of science.
However, critics highlight a major flaw: No human has successfully been revived after cryopreservation to date.
